Skip to main content

and
  1. No Access

    Article

    Loss of HMBOX1 promotes LPS-induced apoptosis and inhibits LPS-induced autophagy of vascular endothelial cells in mouse

    Our previous study revealed that Homeobox containing 1 (HMBOX1), essential for the survival of vascular endothelial cells (VECs), was involved in the progression of atherosclerosis. Knockdown of HMBOX1 promote...

    HanLin Ma, Le Su, **aoYing He, JunYing Miao in Apoptosis (2019)

  2. No Access

    Article

    Effects of annexin A7 inhibitor-ABO on the expression and distribution of long noncoding RNA-CERNA1 in vascular endothelial cells apoptosis

    More and more studies reported that diverse biological roles of long noncoding RNAs were usually dependent on their subcellular location. In our previous study, long noncoding RNA CERNA1 was identified both lo...

    Wei Lu, **aoying He, Le Su, Bao**ang Zhao, JunYing Miao in Apoptosis (2019)

  3. Article

    Open Access

    Stem cell protein Piwil1 endowed endometrial cancer cells with stem-like properties via inducing epithelial-mesenchymal transition

    Stem cell protein Piwil1 functions as an oncogene in various tumor types. However, the exact function and mechanism of Piwil1 in endometrial cancer remains unclear.

    Zheng Chen, Qi Che, **aoying He, Fangyuan Wang, Huihui Wang, Minjiao Zhu in BMC Cancer (2015)

  4. Article

    Open Access

    Suppression of the epithelial-mesenchymal transition by SHARP1 is linked to the NOTCH1 signaling pathway in metastasis of endometrial cancer

    Mechanisms governing the metastasis of endometrial cancer (EC) are poorly defined. Recent data support a role for Enhancer-of-split and hairy-related protein 1 (SHARP1), a basic helix-loop-helix transcription ...

    Yun Liao, **aoying He, Haifeng Qiu, Qi Che, Fangyuan Wang, Wen Lu, Zheng Chen in BMC Cancer (2014)

  5. Article

    Open Access

    FOXA1 promotes tumor cell proliferation through AR involving the Notch pathway in endometrial cancer

    Increasing evidence suggests that forkhead box A1 (FOXA1) is frequently dysregulated in many types of human cancers. However, the exact function and mechanism of FOXA1 in human endometrial cancer (EC) remains ...

    Meiting Qiu, Wei Bao, **gyun Wang, Tingting Yang, **aoying He, Yun Liao in BMC Cancer (2014)

  6. Article

    Erratum to: A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas

    David M. Peereboom, Jeffrey G. Supko, Kathryn A. Carson in Journal of Neuro-Oncology (2010)

  7. No Access

    Article

    A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas

    Ixabepilone is an epothilone, a novel class of non-taxane microtubule stabilizing agents. A phase I/II and pharmacokinetic trial of ixabepilone was conducted in patients with recurrent high-grade gliomas. Adul...

    David M. Peereboom, Jeffrey G. Supko, Kathryn A. Carson in Journal of Neuro-Oncology (2010)

  8. No Access

    Article

    Effect of blood brain barrier permeability in recurrent high grade gliomas on the intratumoral pharmacokinetics of methotrexate: a microdialysis study

    Purpose: Determining whether potentially therapeutic drug exposure is achieved within brain tumors in an exploratory clinical investigation would provide a rational basis for selecting agents for evaluation in ph...

    Jaishri O. Blakeley, Jeffrey Olson, Stuart A. Grossman in Journal of Neuro-Oncology (2009)

  9. No Access

    Article

    Phase I clinical trial of the farnesyltransferase inhibitor BMS-214662 administered as a weekly 24 h continuous intravenous infusion in patients with advanced solid tumors

    Purpose: BMS-214662 is a novel farnesyltransferase (FT) inhibitor that has shown promising suggestions of single agent activity in patients with advanced solid tumors when administered as...

    Joseph P. Eder Jr, David P. Ryan, Leonard Appleman in Cancer Chemotherapy and Pharmacology (2006)